脑部放疗，上午比下午敏感许多！ Y$ U5 ?! y, w
' |/ h( ^& s) y7 H3 f. [
. W8 Z3 d7 J3 {8 A, ^% Y5 {% P1 u
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
! ^+ |! L$ M& _# r% IGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
, e* W. M; K. ]Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
$ t, _+ r' z' z+ I: t1 N4 o, nSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
' f& c7 t* W z) @$ O* [5 m
: V& p; j' a D0 J' M/ e) ]Abstract
' i5 w) n* H3 w! f: KBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
( A, {9 {- i o2 T; v5 v; h6 |$ s! ?0 @# q$ G3 d8 l$ V& V
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
! P' e9 B( t" S
! T% Q9 d ^3 e; O' ARESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
1 K0 w% e( m2 x' U& C% T
. f4 j8 H1 B( r1 N& dCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
+ P) N& K5 I/ e: z8 N7 T! v% t9 Z* |8 k
! p- F6 e$ r9 A8 \/ p- | |
! L! d y4 v# X* \$ s9 d
显身卡
